SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011616
Filing Date
2024-03-28
Accepted
2024-03-28 08:10:46
Documents
97
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1858662
2 ex21-1.htm EX-21.1 4025
3 ex23-1.htm EX-23.1 4917
4 ex31-1.htm EX-31.1 17829
5 ex31-2.htm EX-31.2 17941
6 ex32-1.htm EX-32.1 8028
7 ex32-2.htm EX-32.2 8097
8 ex-97.htm EX-97.0 40116
  Complete submission text file 0001493152-24-011616.txt   7633635

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE imnn-20231231.xsd EX-101.SCH 57658
10 XBRL CALCULATION FILE imnn-20231231_cal.xml EX-101.CAL 82173
11 XBRL DEFINITION FILE imnn-20231231_def.xml EX-101.DEF 223922
12 XBRL LABEL FILE imnn-20231231_lab.xml EX-101.LAB 500131
13 XBRL PRESENTATION FILE imnn-20231231_pre.xml EX-101.PRE 399924
101 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 888357
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15911 | Film No.: 24793636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)